Company page

Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc is a public company traded under the ticker JAZZ in the American market. With a market capitalization of approximately $15.9 billion, the company focuses on developing and commercializing innovative therapies for patients with serious diseases. Their commitment to addressing unmet medical needs drives their research and product development efforts.

JAZZ:NASDAQUpdated August 21, 2026
Jazz Pharmaceuticals Plc logo
Ticker
JAZZ:NASDAQ
Asset type
Stock
Market cap
$16.51B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD